Suven Lifesciences posts strong result

Suven Lifesciences reported strong result with good numbers across the board. The core manufacturing business witnessed robust growth aiding better top-line growth.

The top-line growth for the quarter rose by 19 per cent yoy to Rs. 208 crore in Q4YFY18 vs Rs. 175 crore in Q4FY17. This was largely due to 17.7 per cent yoy growth in manufacturing segment to Rs. 206 crore in Q4FY18.

The EBITDA for the quarter doubled to Rs. 86 crore in Q4FY18 vs Rs. 43 crore in Q4FY7. While the EBITDA margins for the quarter rose substantially by 1660 bps to 41.2 per cent in Q4FY18 vs 24.6 per cent yoy in the previous year's corresponding quarter. This was largely due to favourable inventory changes in Q4FY18.

The resultant bottom-line growth saw 56 per cent yoy growth to Rs. 63 crore in Q4FY18 vs Rs.40 crore in Q4FY17.

The stock closed 4.18 per cent up at Rs.189.45 mark